Digitalization for the benefit of the diabetes' patient
Super Session 3 – Metabolic Diseases
Digitalization is becoming an increasingly important part of healthcare, life sciences and clinical trials. Stakeholders from these areas are contributing to this development in different ways. The session will present various perspectives of how diabetes patients can benefit from such digital revolution.
Moderator(s): Dr. Gaspar Taroncher-Oldenburg - Editor-at-Large, Nature Publishing Group
Dr. Michel de Baar - Executive Director, BD&L - Infectious Diseases, Vaccines, Cardiometabolic, Immunology & Inflammation, MSD Dr. Lars Gustafsson - Expert, Healthcare Digitalization - CGI/KI Mr. Thomas Magnusson - Chairman of the Board, The Diabetes Organisation of Sweden Dr. Damon Tojjar - Managing Director, Easy Diabetes Dr. Rob Harris - Director Science and Technology, Catalent Pharma Solutions